These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2686392)

  • 1. Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. Preliminary report.
    Kuske RR; Perez CA; Grigsby PW; Lovett RD; Jacobs AJ; Galakatos AE; Camel HM; Kao MS
    Am J Clin Oncol; 1989 Dec; 12(6):467-73. PubMed ID: 2686392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective phase I/II studies of definitive irradiation and chemotherapy for advanced gynecologic malignancies.
    Grigsby PW; Graham MV; Perez CA; Galakatos AE; Camel HM; Kao MS
    Am J Clin Oncol; 1996 Feb; 19(1):1-6. PubMed ID: 8554027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I-II study of combined 5-fluorouracil and cisplatin chemotherapy and altered fractionation radiotherapy for advanced squamous cell carcinoma of the cervix.
    Fishman A; Chiu JK; Girtanner RE; Dennis W; Carpenter LS; Lu HH; Woo SY; Kerley JM; Kaplan AL
    Am J Clin Oncol; 1997 Aug; 20(4):342-7. PubMed ID: 9256886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
    Varia MA; Bundy BN; Deppe G; Mannel R; Averette HE; Rose PG; Connelly P
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1015-23. PubMed ID: 9869224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent 5-fluorouracil, daily low-dose cisplatin, and radiotherapy in stage IIIB cervical cancer. A phase II prospective study.
    Hsu WL; Shueng PW; Jen YM; Wu CJ; Liu HS; Su CC; Hwang JM
    Am J Clin Oncol; 1996 Jun; 19(3):263-7. PubMed ID: 8638538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
    Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.
    Calais G; Dorval E; Louisot P; Bourlier P; Klein V; Chapet S; Reynaud-Bougnoux A; Huten N; De Calan L; Aget H; Le Floch O
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):769-75. PubMed ID: 9240645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant bi-weekly combination of cisplatin, infusional 5-fluorouracil and folinic acid followed by concomitant chemoradiotherapy with infusional fluorouracil for high risk operated gastric and gastroesophageal junction adenocarcinoma.
    Uncu D; Ozdemir NY; Aksoy S; Abali H; Oksuzoglu BC; Budakoglu B; Yildiz R; Aslan N; Zengin N
    Asian Pac J Cancer Prev; 2010; 11(6):1493-7. PubMed ID: 21338186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma.
    Resbeut M; Cowen D; Viens P; Noirclerc M; Perez T; Gouvernet J; Delpero JR; Gamerre M; Boubli L; Houvenaeghel G
    Gynecol Oncol; 1994 Jul; 54(1):68-75. PubMed ID: 8020842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy.
    Heaton D; Yordan E; Reddy S; Bonomi P; Lee MS; Lincoln S; Graham J; Dolan T; Miller A; Phillips A
    Gynecol Oncol; 1990 Sep; 38(3):323-7. PubMed ID: 2227542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of carcinoma of the uterine cervix with concomitant cisplatin, 5-fluorouracil and split course hyperfractionated radiotherapy.
    Tubiana-Mathieu N; Bonnier P; Delaby F; Murraciole X; Lejeune C; Hadjadj DJ; Juin P; Piana L
    Eur J Obstet Gynecol Reprod Biol; 1998 Mar; 77(1):95-100. PubMed ID: 9550208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
    Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix.
    Chaney AW; Eifel PJ; Logsdon MD; Morris M; Wharton JT
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):113-8. PubMed ID: 10477014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.